Details of the Drug

General Information of Drug (ID: DMQRNTG)

Drug Name
MP-124
Indication
Disease Entry ICD 11 Status REF
Ischemic stroke 8B11.5Z Phase 1 [1]
Stroke 8B20 Phase 1 [2]
Cross-matching ID
TTD ID
D0YU1L
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Poly [ADP-ribose] polymerase (PARP) TTEBCY8 NOUNIPROTAC Modulator [3]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model. Brain Res. 2011 Sep 2;1410:122-31.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Company report (Mitsubishi Tanabe Pharma)